Sagecast Archive
About this Sagecast: Colin Farrelly answers the question, "Why should fighting aging matter?". He wants to silence the critics that say longevity science is not worthy of pursuing.
About Colin Farrelly: Dr. Farrelly is the Queen's National Scholar in the Department of Political Studies at Queen's University. Read more about Dr. Farrelly here.
[ View ]
About this Sagecast: Dr. Leonard Guarente talks about discoveries in sirtruin biology, specifically that of resveratrol. Resveratrol, a natural compound that is found in red wine, may be the secret to unlocking a longer and healthier life.
About Dr. Guarente: Dr. Guarente, the founder of sirtruin biology, is the Novartis professor at the Massachusetts Institute of Technology. Read more about Dr. Guarente here.
[ View ]
About this Sagecast: Dr. Ingram speaks his mind on the best ways to continue the pursuit for the elusive biomarkers of aging. He believes that expert roundtable discussions are essential to moving the field forward.
About Dr. Ingram: Dr. Ingram is a researcher with the Louisiana State University system. Read more about Dr. Ingram here.
[ View ]
About this Sagecast: Daniel Perry tells us what a biomarker of aging is and why we desperately need to find them. He also explains how we should go about searching for them.
About Daniel Perry: Daniel Perry is the executive director of the non-profit organization, the Alliance for Aging-Research. Read more about Daniel Perry here.
[ View ]
About this Sagecast: Dr. Richard Miller wants us to know how negative attitudes and lack of interest among researchers are having a large impact on the progression of the field. Until attitudes change and genuine interest picks up, we might not find any biomarkers of aging.
About Dr. Richard Miller: Dr. Miller is a professor and researcher at the University of Michigan. Read more about Dr. Miller here.
[ View ]
About this Sagecast: Dr. Huber Warner also weighs in on the successes and failures of the NIA Biology of Aging program. His intuitions about the search for biomarkers are positive, and he has an optimistic outlook for the future of the field.
About Dr. Huber Warner: Dr. Huber Warner is a past program director for the NIA Biology of Aging Program. Read more about Huber Warner here.
[ View ]
About this Sagecast: Dr. Richard Sprott confronts the question, "What did we learn from the National Institute of Aging's Biology of Aging program?"
About Dr. Richard Sprott: Dr. Sprott is the executive director of the Ellison Medical Foundation. Read more about Dr. Sprott here.
[ View ]
About this Sagecast: Dr. Gregory Stock firmly believes that increased longevity will change the way in which wealth is tranferred among generations in families, and it will disrupt the family structure itself.
About Dr. Gregory Stock: Dr. Stock is the CEO of Signum Biosciences. Read more about Dr. Stock here.
[ View ]
[ View ]About this Sagecast: Dr. David Meltzer gives listeners an economist's perspective on analyzing the impact that living longer has on the economy. When we live longer, we spend a greater amount on our income on healthcare, impacting the economy.
About Dr. David Meltzer: Dr. Meltzer is an economist and a professor at the University of Chicago. Read more here.
About this Sagecast: Daniel Perry talks about exciting volunteer opportunities that are emerging for those leaving the workforce. For example, retired members of the community are giving back by teaching prison inmates how to read or tutoring children after school. These types of volunteer jobs not only capitalize on the expertise that retired members of the community have, but they also stimulate and benefit the economy.
About Daniel Perry: Daniel Perry is the executive director of the non-profit organization, the Alliance for Aging Research. Read more about Daniel Perry here.
[ View ]
About this Sagecast: Dr. Robert Fogel offers up the idea that a privatization is in store to succesfully rehab programs like Social Security and Medicare as they falter in the face of a growing boomer population.
About Dr. Robert Fogel: Dr. Fogel is a nobel prize winning economist and professor at the University of Chicago. Read more here.
[ View ]
About this Sagecast: Dr. Jay Olshansky fervently believes that if the population lives longer, then this will enormously benefit the economy. Entitlement program spending will go down and overall economic wealth will only increase.
About Dr. Olshansky: Dr. Olshansky is a professor of public health at the University of Illinois Chicago. Read more about Dr. Olshansky here.
[ View ]
About this Sagecast: Dr. Robert Butler isn't a fan of the anti-aging supplement hoax. He feels as though it gives longevity science a bad rap. He's also not fond of the negative stereotypes Americans have of the older population.
About Dr. Robert Butler: Dr. Butler is the president and CEO of the International Longevity Center. Read more about Dr. Butler here.
[ View ]
About this Sagecast: Dr. Richard Miller talks about what the FDA, CMS, and NIH all have to do with longevity science. He discusses how policy has a role, good or bad, in shaping most important scientific advancements.
About Dr. Richard Miller: Dr. Miller is an associate director for research at the Institute of Gerontology for the University of Michigan's Medical School. Read more about him here.
[ View ]
About this Sagecast: Dr. John Trojanowski shares some of his research findings in Alzheimer's disease biomarkers. He explains how this could relate to the ever elusive biomarkers of aging that many tout as the key to advancing longevity science.
About Dr. John Q. Trojanwoski: Dr. Trojanwoski is a professor and leading researcher in neurological disorders such as Alzheimer's disease. Read more about Dr. Trojanwoski here.
[ View ]
